BROWSE BY
0
Catabasis Pharmaceuticals, Inc. Banner Image

Catabasis Pharmaceuticals, Inc.

  • Ticker CATB
    Exchange NASDAQ More
  • Industry Biotechnology More
  • Sector Healthcare More
Catabasis Pharmaceuticals, Inc. Logo Image
  • 11-50 Employees
  • Based in Boston, Massachusetts
At Catabasis Pharmaceuticals, their mission is to bring hope and life-changing therapies to patients and their families. Their lead program is edasalonexent, an NF-kB inhibitor in Phase 3 development for the treatment of Duchenne muscular dystrophy.
Visit website
REPORT RATINGS
4.8 / 5.0 (202)

Catabasis Pharmaceuticals, Inc. reports have an aggregate usefulness score of 4.8 based on 202 reviews.

Catabasis Pharmaceuticals, Inc.

Most Recent Annual Report

Catabasis Pharmaceuticals, Inc.
MOST RECENT 2020 Annual Report and Form 10K
View PDF View Form 10K (HTML)

Older/Archived Annual Reports

Show 2 older reports
x
Catabasis Pharmaceuticals, Inc. Logo Image

Rate This Report

Your vote helps our reports be more useful
Rating Saved!

Thank you for your feedback!